Supplementary Financial Results Materials for the Second Quarter of the Fiscal Year Ending March 2027 | Advanex Inc. (5998) timely disclosure

Worth reading

44Recurring

Scored from 5 of 6 sections

Direction

Mixed performance

Direction inferred from the company’s description.

Scale

1403

¥ million (year-on-year increase in revenue)

Wording

Conditional

How definitive the wording is.

Contents of this document

Supplementary materials to the earnings summarySecond quarter of the fiscal year ending March 20277 items taken from the company’s own explanation

Financial Results Figures (The key points of this material are explained below)

Net Sales¥15,941 million+9.7%

Operating profit¥748 million+19.5%

Ordinary income¥419 million-25.8%

Net income¥1,504 million+289.5%

Operating profit margin4.7 %

Results for the three months of the current quarter

Net Sales

¥8,088 million

Operating profit

¥431 million

Full-year earnings forecast

Net Sales

¥30,000 million

Operating profit

¥1,500 million

Ordinary income

¥1,200 million

Profit attributable to owners of the parent

¥2,000 million

Dividend per share

50 yen

What the company explained in this material

Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.

Foreign exchange losses

¥178 million

Foreign exchange gain in the same period of the previous year

¥48 million

Extraordinary gain from the transfer of the Singapore factory and other transactions

¥1,393 million

Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.

Exchange rate

¥150 /US$

Key KPIsA metric the company considers important as a management benchmark.

Sales to the automotive market

¥7,664 million+6.5%

Sales to the medical device market

¥3,450 million+16.8%

Sales to the aircraft equipment market

¥1,036 million+48.6%

Coil thread sales

¥1,204 million+46.7%

Segment results

Japan

Net Sales

First half of the fiscal year ending March 2026¥4,639 million

First half of the fiscal year ending March 2027¥4,851 million

Segment profit

First half of the fiscal year ending March 2026¥160 million

First half of the fiscal year ending March 2027¥131 million

Americas

Net Sales

First half of the fiscal year ending March 2026¥3,016 million

First half of the fiscal year ending March 2027¥3,344 million

Segment profit

First half of the fiscal year ending March 2026¥327 million

First half of the fiscal year ending March 2027¥68 million

Europe

Net Sales

First half of the fiscal year ending March 2026¥1,474 million

First half of the fiscal year ending March 2027¥2,043 million

Segment profit

First half of the fiscal year ending March 2026¥-153 million

First half of the fiscal year ending March 2027¥69 million

Asia

Net Sales

First half of the fiscal year ending March 2026¥5,406 million

First half of the fiscal year ending March 2027¥5,702 million

Segment profit

First half of the fiscal year ending March 2026¥288 million

First half of the fiscal year ending March 2027¥471 million

Financial targets

Debt-to-equity ratio

1.4 Times

As ofEnd of September 2026

Capital expenditures

¥887 million cumulative 2Q

Annual Dividend

¥50 per share

Contents of this document
Item	Details
Document type	Supplementary materials to the earnings summary
Fiscal Period Covered	Second quarter of the fiscal year ending March 2027
Net Sales	¥15,941 million (YoY +9.7%)
Operating profit	¥748 million (YoY +19.5%)
Ordinary income	¥419 million (YoY -25.8%)
Net income	¥1,504 million (YoY +289.5%)
Operating profit margin	4.7 %
Results for the three months of the current quarter	Net Sales ¥8,088 million / Operating profit ¥431 million
Full-year earnings forecast	Net Sales ¥30,000 million / Operating profit ¥1,500 million / Ordinary income ¥1,200 million / Profit attributable to owners of the parent ¥2,000 million / Dividend per share 50 yen
Segment results	Japan Net Sales First half of the fiscal year ending March 2026 ¥4,639 million / First half of the fiscal year ending March 2027 ¥4,851 million / Segment profit First half of the fiscal year ending March 2026 ¥160 million / First half of the fiscal year ending March 2027 ¥131 million / Americas Net Sales First half of the fiscal year ending March 2026 ¥3,016 million / First half of the fiscal year ending March 2027 ¥3,344 million / Segment profit First half of the fiscal year ending March 2026 ¥327 million / First half of the fiscal year ending March 2027 ¥68 million / Europe Net Sales First half of the fiscal year ending March 2026 ¥1,474 million / First half of the fiscal year ending March 2027 ¥2,043 million / Segment profit First half of the fiscal year ending March 2026 ¥-153 million / First half of the fiscal year ending March 2027 ¥69 million / Asia Net Sales First half of the fiscal year ending March 2026 ¥5,406 million / First half of the fiscal year ending March 2027 ¥5,702 million / Segment profit First half of the fiscal year ending March 2026 ¥288 million / First half of the fiscal year ending March 2027 ¥471 million
Breakdown of Factors Affecting the Change	Foreign exchange losses ¥178 million / Foreign exchange gain in the same period of the previous year ¥48 million / Extraordinary gain from the transfer of the Singapore factory and other transactions ¥1,393 million
Key KPIs	Sales to the automotive market ¥7,664 million (YoY +6.5%) / Sales to the medical device market ¥3,450 million (YoY +16.8%) / Sales to the aircraft equipment market ¥1,036 million (YoY +48.6%) / Coil thread sales ¥1,204 million (YoY +46.7%)
Assumptions Underlying the Business Outlook	Exchange rate ¥150 /US$
Financial targets	Debt-to-equity ratio 1.4 Times
Annual Dividend	¥50 per share
Capital expenditures	¥887 million (cumulative 2Q)

Items this document does not state (15)

Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Higher sales to the automotive, medical and aircraft sectors drove the revenue increase. Although the effects of higher crude oil and raw-material prices and US tariffs continued, operating profit increased. Ordinary profit was affected by the recording of ¥178 million in foreign exchange losses resulting from the revaluation of held assets and liabilities, while interim net income was boosted by ¥1,393 million in special gains from the transfer of the Singapore plant and other transactions.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.